mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.001 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.001 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |